Penumbra, Inc.
General ticker "PEN" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $10.1B (TTM average)
Penumbra, Inc. follows the US Stock Market performance with the rate: 33.3%.
Estimated limits based on current volatility of 0.4%: low 338.70$, high 341.58$
Factors to consider:
- Total employees count: 3900 as of 2022
- US accounted for 75.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Strategic risks and growth management, Geopolitical risks, IT system failures, Financing risks, Facility expansion challenges
- Current price 19.8% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [180.47$, 272.65$]
- 2025-12-31 to 2026-12-31 estimated range: [188.81$, 284.26$]
Financial Metrics affecting the PEN estimates:
- Negative: with PPE of 84.0 at the end of fiscal year the price was high
- Positive: -4.75 < Operating profit margin, % of 0.78
- Positive: 0.01 < Operating cash flow per share per price, % of 1.81
- Positive: Investing cash flow per share per price, % of 0.83 > -0.63
- Positive: Industry inventory ratio change (median), % of -1.37 <= -0.16
Short-term PEN quotes
Long-term PEN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,058.52MM | $1,194.62MM | $1,403.66MM |
| Operating Expenses | $984.97MM | $1,185.34MM | $1,214.42MM |
| Operating Income | $73.55MM | $9.28MM | $189.25MM |
| Non-Operating Income | $6.10MM | $11.59MM | $15.88MM |
| R&D Expense | $102.64MM | $94.78MM | $89.77MM |
| Income(Loss) | $79.65MM | $20.87MM | $205.12MM |
| Taxes | $-11.30MM | $6.86MM | $27.44MM |
| Profit(Loss)* | $90.95MM | $14.01MM | $177.69MM |
| Stockholders Equity | $1,178.94MM | $1,150.93MM | $1,427.60MM |
| Inventory | $388.02MM | $406.74MM | $431.55MM |
| Assets | $1,556.31MM | $1,533.18MM | $1,826.52MM |
| Operating Cash Flow | $97.33MM | $168.48MM | $238.66MM |
| Capital expenditure | $15.21MM | $21.18MM | $63.73MM |
| Investing Cash Flow | $-16.08MM | $77.62MM | $-404.59MM |
| Financing Cash Flow | $16.20MM | $-87.01MM | $26.53MM |
| Earnings Per Share** | $2.37 | $0.36 | $4.57 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.